Healthcare, Nutrition, and Medical Devices by Abbott

0.2026
0.0143
6.59 %
Daily range
Weekly range
  • Dan Blystone
  • 10 hours ago
Abbott Laboratories stock gains as Norges Bank acquires new institutional position
Abbott Laboratories (ABT) stock is trading at $90.18, gaining 3.67% on the day. The price sits above its key short- and medium-term moving averages, reflecting strong ...
  • Emilio Ghigini
  • 12 hours ago
Abbott Laboratories shares jump as stock buying pressure builds
Abbott Laboratories (ABT) is currently trading at $90.09, climbing $3.10 or 3.56% today. The stock sits above its 20-day moving average but remains below both the 50-day and 200-day averages, ...
  • Sholanke Dele
  • 26.05.2026
ABT shares hold steady near support levels as RSI approaches extreme lows: weekly report
Abbott Laboratories (ABT) is trading at $86.43, having dropped $0.98 (1.16%) over the past week and finishing at the very bottom of the weekly range. The asset remains ...
  • Oleg Tkachenko
  • 18.05.2026
Raised full-year 2026 outlook lifts Abbott stock 3.18%
Abbott Laboratories (ABT) is trading at $87.16 after advancing 3.18% on the day and currently sits below its key moving ...
  • Jainam Mehta
  • 18.05.2026
Abbott stock posts modest gain amid fragile momentum below MA-20 resistance: weekly review
Abbott Laboratories (ABT) is trading at $87.20, having advanced $2.73 or 3.10% over the past week. The price remains well below its W1 MA-20 ($105.87), MA-50 ($120.53), ...
  • Dmytro Kharkov
  • 12.05.2026
Q1 2026 earnings beat sends Abbott stock higher by 3.04%
Abbott Laboratories (ABT) is trading at $85.07, rising 3.04% on the day and showing upward momentum. The price remains below its key moving averages, suggesting ...
  • Sholanke Dele
  • 11.05.2026
Why is Abbott Laboratories stock down today?
Abbott Laboratories (ABT) is trading at $82.48, having declined $1.82 or 2.16% for the day. The stock remains well below its 20-, 50-, and 200-day moving averages, reflecting ongoing selling ...
  • Oleg Tkachenko
  • 05.05.2026
Abbott stock tumbles below key moving averages as sellers dominate momentum: weekly outlook
Abbott Laboratories (ABT) ended the week at $86.64, falling $2.83 or 3.16% over the last seven trading days. The stock is trading well below its weekly MA-20 ($108.05), ...
  • Oleg Tkachenko
  • 04.05.2026
Selling pressure pushes Abbott Laboratories stock lower in today's trading
Abbott Laboratories (ABT) is trading at $87.42, marking a daily drop of $2.05 or 2.29%. The stock sits well below its 20-day ($96.43), 50-day ($104.06), and 200-day ($120.55) moving averages, ...
  • Hanna Syniavska
  • 14.04.2026
+1.14% for Abbott stock as sellers limit gains below key resistance levels
Abbott received the number one ranking in the health care sector and placed fourth overall on Fortune Magazine’s America’s Most Innovative Companies list.Abbott said its health technology and ...
  • Ashutosh Sureka
  • 13.04.2026
Abbott Laboratories stock edges lower as Team Abbott spotlights runner's Boston Marathon story
Abbott Laboratories shared a story from a runner named Chris, who participated in the Boston Marathon, as part of its #TeamAbbott community initiative.The company is encouraging people to learn ...
  • Dmytro Kharkov
  • 10.04.2026
-3.05% for Abbott Laboratories stock as persistent selling outweighs support
Abbott Laboratories (ABT) is trading at $99.59, down 3.05% on the day, and remains well below its SMA-20 ($105.03), SMA-50 ($109.04), and SMA-200 ($123.69). This ...
  • Andrey Mastykin
  • 30.03.2026
Exact Sciences biotech accolade leaves Abbott stock consolidating amid bearish momentum and oversold signals
Abbott congratulated its new cancer diagnostics colleagues from Exact Sciences for being recognized on the Fast Company Most Innovative Companies biotech list.Abbott stated that advancing cancer ...
  • Hanna Syniavska
  • 26.03.2026
Abbott stock price forecast: bearish momentum dominates as ABT risks retest of 52-week low
Abbott landed the number four spot on Fortune Magazine's list of America's Most Innovative Companies, the company said. Abbott shared the news on its official social media account.Abbott stated ...
  • Artem Shendetskii
  • 25.03.2026
Abbott ranks number 4 among America most innovative companies after 138 years in operation
Abbott has been recognized as number 4 on Fortune Magazine America Most Innovative Companies list, affirming its longstanding dedication to health and innovation. The company, which traces its ...
  • Andrey Mastykin
  • 18.03.2026
Selling pressure pushes Abbott Laboratories stock lower in today's trading
Abbott Laboratories (ABT) is currently trading at $108.45, marking a daily decline of 2.04%. The stock is positioned below its 20-, 50-, and 200-day moving averages, indicating persistent seller ...
  • Oleg Tkachenko
  • 13.03.2026
Abbott Laboratories stock consolidates as bearish momentum continues after weak technical signals
Abbott Laboratories (ABT) is trading at $107.98, down 0.15% on the day and holding well below its SMA-20 ($112.73), SMA-50 ($115.25), and SMA-200 ($126.42) levels, ...
  • Parshwa Turakhiya
  • 02.03.2026
Abbott Laboratories stock forecast for 2030: Exact Sciences acquisition reshapes growth outlook toward $180
​Abbott has just priced $20 billion in senior notes to finance the largest acquisition in its history. On February 23, Abbott reached a pricing agreement with a group of major investment banks ...
  • Oleg Tkachenko
  • 22.01.2026
Abbott reports solid double-digit earnings growth in 2025
Abbott has revealed its full-year 2025 financial results, showcasing impressive double-digit earnings growth. The company attributes this success to the advancement of key new products and ...
  • Hlib Chabaniuk
  • 20.01.2026
Abbott enhances heart procedure with advanced catheter technology
Abbott has introduced the TactiFlex Duo Ablation Catheter, Sensor Enabled, to improve the safety and precision of treating abnormal heart rhythms, particularly atrial fibrillation (AFib). This ...